Loading…
Quanterix has entered into a Phase 2 contract with the National Institutes of Health worth $18.2 million to develop, scale up and deploy a SARS-CoV-2 antigen test based on its Simoa technology. The contract runs through September 2021.
Tantus Technologies was awarded a 5-year, $5 million IDIQ contract by the NIH National Institute of Environmental Health Sciences to provide NEAD DME Support Services.